Oral dehydroepiandrosterone inhibits the growth of human pancreatic cancer in nude mice

Journal of Surgical Research

Volumn 79, Issue 2, 1998, Pages 154-157

  Muscarella, Peter ^a   Boros, Laszlo G ^a   Fisher, William E ^a   Rink, Cameron ^a   Melvin, W Scott ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Dehydroepiandrosterone; Pancreatic cancer

Indexed keywords

PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0032190016     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5417     Document Type: Article

References (25)

1. Melvin W. S., Boros L. G., Muscarella P. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferationin vitroin vivo. Surgery. 121:1997;392.
2. Cancer Facts and Figures - 1996. 1996;American Cancer Society, New York.
3. Gudjonsson B., Livstone E. M., Spiro H. M. Cancer of the pancreas: Diagnostic accuracy and survival statistics. Cancer. 42:1978;2494.
4. Zumoff B., Levin J., Rosenfeld R. S., Markham M., Strain G. W., Fukushima D. K. Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res. 41:1981;3360.
5. Bulbrook R. D., Hayward J. L. Abnormal urinary steroid excretion and subsequent breast cancer. Lancet. 1:1967;519.
6. Bulbrook R. D., Hayward J. L., Spicer C. C. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet. 2:1971;395.
7. Pashko L. L., Hard G. C., Rovito R. J., Williams J. R., Sobel E. L., Schwartz A. G. Inhibition of 7,12-Dimethylbenz[a. Cancer Res. 45:1985;164.
8. Schwartz A. G., Fairman D. K., Polansky M., Lewbart M. L., Pashko L. L. Inhibition of 7,12-Dimethylbenz[aO. Carcinogenesis. 10:1989;1809.
9. Ratko T. A., Detrisac C. J., Mehta R. G., Kellof G. J., Moon R. C. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analog of dehydroepiandrosterone. Cancer Res. 51:1991;481.
10. Moore M. A., Thamavit W., Tsuda H., Sato K., Ichihara A., Ito N. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n. Carcinogenesis. 7:1986;311.
11. vy. Cancer Res. 39:1979;1129.
12. Nyce J. W., Magee P. N., Hard G. C., Schwartz A. G. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis. 5:1984;57.
13. Tagliaferro A. R., Roebuck B. D., Ronan A. M., Meeker L. D. Enhancement of pancreatic carcinogenesis by dehydroepiandrosterone. Exercise, Calories, Fat, and Cancer. 1992;Plenum, New York. p. 119-129.
14. Thornton M., Moore M. A., Ito N. Modifying influences of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic preneoplastic lesions in the rat. Carcinogenesis. 10:1989;407.
15. Tsutsumi M., Noguchi N., Okita S. Inhibitory effects of sulfation inhibitors on initiation of pancreatic ductal carcinogenesis byNhamsters. Carcinogenesis. 16:1995;457.
16. Pashko L. L., Lewbart L. L., Schwartz A. G. Inhibition of 12-O. Carcinogenesis. 12:1991;2189.
17. Greenway B. A. Carcinoma of the exocrine pancreas: A sex hormone responsive tumour. Br. J. Surg. 74:1987;441.
18. Lhoste E. F., Roebuck B. D., Stern J. E., Longnecker D. S. Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat. Pancreas. 2:1987;38.
19. Lhoste E. F., Roebuck B. D., Brinck-Johnsen T., Longnecker D. S. Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats. Carcinogenesis. 8:1987;699.
20. Sumi C., Longnecker D. S., Roebuck B. D., Brinck-Johnsen T. Inhibitory effects of estrogen and castration on the early stage pancreatic carcinogenesis in Fischer rats treated with azaserine. Cancer Res. 49:1989;2332.
21. Andren-Sandberg A. Androgen influence on exocrine pancreatic cancer. Int. J. Panc. 4:1989;363.
22. Sandberg A. A., Rosenthal H. E. Steroid receptors in exocrine glands: The pancreas and the prostate. J. Steroid Biochem. 11:1979;293.
23. Sandberg A. A., Kirdany R. Y., Varkarakis M. J., Murphy G. P. Estrogen receptor protein in pancreas. Steroids. 22:1973;259.
24. Posette A. Demonstration of an androgen receptor in rat pancreas. Biochem. J. 157:1976;229.
25. Boccuzzi G., DiMonaco M., Brignardello E. Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line. Anticancer Res. 13:1993;2267.